Daxor (DXR) Corporation announces significant expansion of its blood volume analysis, BVA, capabilities in three new hospitals. This growth is accelerated by the widespread adoption of Daxor’s ezBVA Lab service – a cutting-edge, CLIA-certified facility delivering precise, on-demand blood volume analysis results within 24 hours. This diagnostic solution has driven strong sales momentum as healthcare providers embrace the clinical and economic benefits of Daxor’s innovative technology. Recent sales wins include: Leading regional referral center in Philadelphia’s northern suburbs implementing ezBVA Lab service for outpatient heart failure management with planned inpatient expansion; Premier northern Kentucky hospital adopting ezBVA Lab service to enhance outpatient heart failure diagnostic capabilities; Arkansas community hospital integrating ezBVA Lab service to optimize outpatient heart failure treatment protocols
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Daxor to showcase blood volume analysis at Cardiovascular Transforum conference
- Daxor announces new data at ACC on blood volume analysis
- Daxor announces submission of Daxor BVA to FDA
- Daxor announces new data from Duke University on BVA at ACC
- Daxor expands blood volume analysis technology across three networks